Biological Psychiatry
Ketamine shows significant therapeutic benefit in people with treatment-resistant depression
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
Psychology & Psychiatry
May 19, 2013 |
4.9 / 5 (7) |
1
|
Genetic risk for schizophrenia is connected to reduced IQ
The relationship between the heritable risk for schizophrenia and low intelligence (IQ) has not been clear. Schizophrenia is commonly associated with cognitive impairments that may cause functional disability. There are clues ...
Psychology & Psychiatry
May 16, 2013 |
4.5 / 5 (2) |
0
|
Autism risk spotted at birth in abnormal placentas
Researchers at the Yale School of Medicine have figured out how to measure an infant's risk of developing autism by looking for abnormalities in his/her placenta at birth, allowing for earlier diagnosis and ...
Autism spectrum disorders
Apr 25, 2013 |
3.8 / 5 (4) |
0
|
Human emotion: We report our feelings in 3-D
Like it or not and despite the surrounding debate of its merits, 3-D is the technology du jour for movie-making in Hollywood. It now turns out that even our brains use 3 dimensions to communicate emotions.
Psychology & Psychiatry
Mar 26, 2013 |
5 / 5 (1) |
1
|
Tickling the brain with magnetic stimulation improves memory in schizophrenia
Cognitive impairments are disabling for individuals with schizophrenia, and no satisfactory treatments currently exist. These impairments affect a wide range of cognition, including memory, attention, verbal and motor skills, ...
Psychology & Psychiatry
Mar 12, 2013 |
5 / 5 (3) |
0
|
Worming our way to new treatments for Alzheimer's disease
According to a 2012 World Health Organization report, over 35 million people worldwide currently have dementia, a number that is expected to double by 2030 (66 million) and triple by 2050 (115 million). Alzheimer's disease, ...
Alzheimer's disease & dementia
Mar 07, 2013 |
5 / 5 (2) |
0
|
Schizophrenia genes increase chance of IQ loss
People who are at greater genetic risk of schizophrenia are more likely to see a fall in IQ as they age, even if they do not develop the condition.
Psychology & Psychiatry
Feb 21, 2013 |
not rated yet |
0
|
Life scientists identify drug that could aid treatment of anxiety disorders
(Medical Xpress)—The drug scopolamine has been used to treat a variety of conditions, including nausea and motion sickness. A new study by UCLA life scientists suggests that it may also be useful in treating anxiety disorders.
Psychology & Psychiatry
Feb 21, 2013 |
not rated yet |
0
|
Scopolamine: An old drug with new psychiatric applications
Scopolamine is an anticholinergic drug with many uses. For example, it prevents nausea, vomiting, and motion sickness.
Psychology & Psychiatry
Feb 12, 2013 |
5 / 5 (2) |
0
|
Researchers spot attention deficits in babies who later develop autism
Researchers at Yale School of Medicine are able to detect deficits in social attention in infants as young as six months of age who later develop Autism Spectrum Disorders (ASD). Published in the current issue of Biological Ps ...
Autism spectrum disorders
Feb 05, 2013 |
5 / 5 (1) |
0
|
If you are impulsive, take modafinil and count to 10
Poor impulse control contributes to one's inability to control the consumption of rewarding substances, like food, alcohol, and other drugs. This can lead to the development of addiction. FDA-approved medications for alcoholism, ...
Psychology & Psychiatry
Feb 01, 2013 |
4 / 5 (4) |
1
|
People with low risk for cocaine dependence have differently shaped brain to those with addiction
People who take cocaine over many years without becoming addicted have a brain structure which is significantly different from those individuals who developed cocaine-dependence, researchers have discovered. New research ...
Psychology & Psychiatry
Jan 17, 2013 |
4.3 / 5 (3) |
0
|
Brain imaging identifies bipolar risk
(Medical Xpress)—Researchers from the Black Dog Institute and University of NSW have used brain imaging technology to show that young people with a known genetic risk of bipolar but no clinical signs of ...
Psychology & Psychiatry
Dec 17, 2012 |
not rated yet |
0
|
Experimental agent briefly eases depression rapidly in test: Works in brain like ketamine, with fewer side effects
(Medical Xpress)—A drug that works through the same brain mechanism as the fast-acting antidepressant ketamine briefly improved treatment-resistant patients' depression symptoms in minutes, with minimal untoward side effects, ...
Psychology & Psychiatry
Dec 11, 2012 |
5 / 5 (1) |
0
|
Drug helps women who stop smoking keep weight off
A medication being tested to help smokers kick the habit also may help avoid the weight gain that is common after quitting but only in women, according to a study published in the December issue of Biological Psychiatry. This i ...
Psychology & Psychiatry
Dec 10, 2012 |
1 / 5 (1) |
0
|
